Lockwood; Samuel Fournier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lockwood; Samuel Fournier.The latest application filed is for "structural carotenoid analogs for the inhibition and amelioration of disease".

Company Profile

0.10.21

Lockwood; Samuel Fournier - Lake Linden MI
Lockwood; Samuel Fournier - Lago Vista TX
Lockwood, Samuel Fournier - LakeLinden MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Carotenoid analogs or derivatives for controlling connexin 43 expression Grant 7,763,649 - Lockwood , et al. July 27, 2	2010-07-27
Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease Grant 7,723,327 - Lockwood , et al. May 25, 2	2010-05-25
Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation Grant 7,691,901 - Lockwood , et al. April 6, 2	2010-04-06
Structural carotenoid analogs for the inhibition and amelioration of disease Grant 7,592,449 - Lockwood , et al. September 22, 2	2009-09-22
Carotenoid analogs or derivatives for the inhibition and amelioration of disease Grant 7,521,584 - Lockwood , et al. April 21, 2	2009-04-21
Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease Grant 7,375,133 - Lockwood , et al. May 20, 2	2008-05-20
Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease Grant 7,345,091 - Lockwood , et al. March 18, 2	2008-03-18
Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease Grant 7,320,997 - Lockwood , et al. January 22, 2	2008-01-22
Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury Grant 7,317,008 - Lockwood , et al. January 8, 2	2008-01-08
Structural carotenoid analogs for the inhibition and amelioration of disease Grant 7,145,025 - Lockwood , et al. December 5, 2	2006-12-05
Structural carotenoid analogs for the inhibition and amelioration of disease App 20060229446 - Lockwood; Samuel Fournier ; et al.	2006-10-12
Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation App 20060058269 - Lockwood; Samuel Fournier ; et al.	2006-03-16
Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation App 20050261254 - Lockwood, Samuel Fournier ; et al.	2005-11-24
Carotenoid ether analogs or derivatives for controlling connexin 43 expression App 20050148517 - Lockwood, Samuel Fournier ; et al.	2005-07-07
Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury App 20050143475 - Lockwood, Samuel Fournier ; et al.	2005-06-30
Carotenoid analogs or derivatives for the inhibition and amelioration of disease App 20050113372 - Lockwood, Samuel Fournier ; et al.	2005-05-26
Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease App 20050090469 - Lockwood, Samuel Fournier ; et al.	2005-04-28
Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease App 20050075316 - Lockwood, Samuel Fournier ; et al.	2005-04-07
Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease App 20050075337 - Lockwood, Samuel Fournier ; et al.	2005-04-07
Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease App 20050065096 - Lockwood, Samuel Fournier ; et al.	2005-03-24
Carotenoid ether analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury App 20050065097 - Lockwood, Samuel Fournier ; et al.	2005-03-24
Carotenoid ester analogs or derivatives for controlling C-reactive protein levels App 20050059635 - Lockwood, Samuel Fournier ; et al.	2005-03-17
Carotenoid analogs or derivatives for controlling C-reactive protein levels App 20050059659 - Lockwood, Samuel Fournier ; et al.	2005-03-17
Carotenoid ether analogs or derivatives for controlling C-reactive protein levels App 20050049248 - Lockwood, Samuel Fournier ; et al.	2005-03-03
Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury App 20050037995 - Lockwood, Samuel Fournier ; et al.	2005-02-17
Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease App 20050026874 - Lockwood, Samuel Fournier ; et al.	2005-02-03
Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease App 20050009758 - Lockwood, Samuel Fournier ; et al.	2005-01-13
Carotenoid ester analogs or derivatives for controlling connexin 43 expression App 20050009788 - Lockwood, Samuel Fournier ; et al.	2005-01-13
Carotenoid analogs or derivatives for controlling connexin 43 expression App 20050009930 - Lockwood, Samuel Fournier ; et al.	2005-01-13
Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease App 20050004235 - Lockwood, Samuel Fournier ; et al.	2005-01-06
Structural carotenoid analogs for the inhibition and amelioration of disease App 20040162329 - Lockwood, Samuel Fournier ; et al.	2004-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.